Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
NEW YORK (Reuters Health) – The combination of epirubicin and ifosfamide is effective in patients with relapsed or refractory small cell lung cancer (SCLC), researchers from France report…
NEW YORK (Reuters Health) – Cervical preparation with prostaglandins before outpatient hysteroscopy does not reduce pain in women of reproductive age, researchers from UK report in the July…
NEW YORK (Reuters Health) – Geographically, higher rates of surgery for early stage nonsmall cell lung cancer (NSCLC) are associated with improved survival, even in older and sicker…
NEW YORK (Reuters Health) – In patients newly diagnosed inoperable pancreatic cancer, it’s worth considering celiac plexus neurolysis (CPN) for pain control at the same time that endoscopic…
NEW YORK (Reuters Health) – Postmenopausal women with ovarian cysts detected on ultrasound are not at increased risk of developing ovarian cancer or, for that matter, breast or…
NEW YORK (Reuters Health) – Five-year survival rates are not significantly different for patients with esophagogastric cancer whether they undergo transthoracic or transhiatal esophagectomy, according to the findings…
NEW YORK (Reuters Health) – Pegylated liposomal doxorubicin may be an alternative to paclitaxel in combination with carboplatin for advanced ovarian cancer, based on the results of an…
NEW YORK (Reuters Health) – Whole lung irradiation, used to treat pulmonary metastases of solid malignancies in children, can lead to increasing pulmonary problems, Tennessee-based researchers report in…
NEW YORK (Reuters Health) – Most patients with differentiated thyroid cancer metastasized to bone benefit from iodine-131 therapy, with stabilization of disease and significant reduction in pain, a…
NEW YORK (Reuters Health) – Combining an EGFR-directed tyrosine kinase inhibitor with conventional chemotherapy does not seem to be a good treatment strategy for lung cancer. According to…
